Oppenheimer Maintains Outperform Rating on Wave Life Sciences, Sets $29 Target
Oppenheimer maintained its Outperform rating on Wave Life Sciences and set a $29 price target. The note cited a 740.6% implied upside from the Oct. 27 close of $3.45.
Story updates
12:50:02 PM UTC
SquawkNews
08:49 AM EDT, 10/28/2026 (MT Newswires) -- Wave Life Sciences (WVE) has an average rating of buy and